Marcinkiewicz, Anna M.
Zhang, Wenhao
Shanbhag, Aakash
Miller, Robert J. H.
Lemley, Mark
Ramirez, Giselle
Buchwald, Mikolaj
Killekar, Aditya
Kavanagh, Paul B.
Feher, Attila
Miller, Edward J.
Einstein, Andrew J.
Ruddy, Terrence D.
Liang, Joanna X.
Builoff, Valerie
Ouyang, David
Berman, Daniel S.
Dey, Damini
Slomka, Piotr J.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R01HL089765)
Article History
Received: 2 October 2024
Accepted: 18 February 2025
First Online: 13 March 2025
Competing interests
: Dr. Marcinkiewicz received consulting fees from APQ Health. Dr. Robert Miller received consulting fees and research support from Pfizer. Drs. Berman and Slomka, and Paul B. Kavanagh participate in software royalties for QPS software at Cedars-Sinai Medical Center. Dr. Slomka has received consulting fees from Synektik. Drs. Berman, Einstein, and Edward Miller have served or currently serve as consultants for GE Healthcare. Dr. Einstein has received speaker fees from Ionetix; has received consulting fees from W. L. Gore & Associates; has received authorship fees from Wolter Kluwer Healthcare-UpToDate; has served on a scientific advisory board for Canon Medical Systems; and has received grants to his institution from Attralus, Bruker, Canon Medical Systems, Eidos Therapeutics, Intellia Therapeutics, Ionis Pharmaceuticals, Neovasc, Pfizer, Roche Medical Systems, and W. L. Gore & Associates. Dr. Ruddy has received research grant support from GE Healthcare and Advanced Accelerator Applications. Dr. David Ouyang reported having a patent pending for EchoNet-LVH. The remaining authors have nothing to disclose.